Extension of Time to File SOU

FIRSTCARE

USPharma Ltd.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88165859
LAW OFFICE ASSIGNED LAW OFFICE 110
MARK SECTION
MARK FIRSTCARE (see, http://uspto.report/TM/88165859/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT FIRSTCARE
OWNER SECTION (current)
NAME USPharma Ltd.
MAILING ADDRESS 13900 NW 57th Court
CITY Miami Lakes
STATE Florida
ZIP/POSTAL CODE 33014
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME USPharma Ltd.
MAILING ADDRESS 13900 NW 57th Court
CITY Miami Lakes
STATE Florida
ZIP/POSTAL CODE 33014
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME William West
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE W-L-O@outlook.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) william.west@uspharmaltd.com
CORRESPONDENCE INFORMATION (proposed)
NAME William West
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE W-L-O@outlook.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) william.west@uspharmaltd.com
DOCKET/REFERENCE NUMBER 11009-FC
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations and substances for the treatment of allergy symptoms, bacterial infections, cough, inflammation, nasal congestion, pain, sleep disorders, ulcers, and viral infections
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT promotional activities ; steps to acquire distributors ; tooling and packaging
ALLOWANCE MAIL DATE 03/19/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /manesh dixit/
SIGNATORY'S NAME Manesh Dixit
SIGNATORY'S POSITION chief executive officer (CEO)
DATE SIGNED 09/15/2020
SIGNATORY'S PHONE NUMBER (305) 698-4600
FILING INFORMATION
SUBMIT DATE Wed Sep 16 10:26:34 ET 2020
TEAS STAMP USPTO/ESU-XXXX:XXXX:XXXX:
XXX:XXXX:XXXX:XXXX:XXXX-2
0200916102634250810-88165
859-750ad9893f859e79a2954
34cf08d992be870a24994f5ed
808f1ab5d181e16cef79-CC-2
6325124-20200915155550486
792



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: FIRSTCARE (see, http://uspto.report/TM/88165859/mark.png)
SERIAL NUMBER: 88165859

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: USPharma Ltd., having an address of
      13900 NW 57th Court
      Miami Lakes, Florida 33014
      United States
      Email: XXXX
Proposed: USPharma Ltd., having an address of
      13900 NW 57th Court
      Miami Lakes, Florida 33014
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 03/19/2019.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment of allergy symptoms, bacterial infections, cough, inflammation, nasal congestion, pain, sleep disorders, ulcers, and viral infections

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: promotional activities ; steps to acquire distributors ; tooling and packaging

Correspondence Information (current):
      William West
      PRIMARY EMAIL FOR CORRESPONDENCE: W-L-O@outlook.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): william.west@uspharmaltd.com

Correspondence Information (proposed):
      William West
      PRIMARY EMAIL FOR CORRESPONDENCE: W-L-O@outlook.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): william.west@uspharmaltd.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /manesh dixit/      Date Signed: 09/15/2020
Signatory's Name: Manesh Dixit
Signatory's Position: chief executive officer (CEO)
Signatory's Phone: (305) 698-4600

RAM Sale Number: 88165859
RAM Accounting Date: 09/16/2020

Serial Number: 88165859
Internet Transmission Date: Wed Sep 16 10:26:34 ET 2020
TEAS Stamp: USPTO/ESU-XXXX:XXXX:XXXX:XXX:XXXX:XXXX:X
XXX:XXXX-20200916102634250810-88165859-7
50ad9893f859e79a295434cf08d992be870a2499
4f5ed808f1ab5d181e16cef79-CC-26325124-20
200915155550486792



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed